etidronate has been researched along with Lupus Erythematosus, Systemic in 2 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cohort study in a tertiary care university affiliated hospital in corticosteroid treated patients, with polymyalgia rheumatica, asthma, systemic lupus erythematosus, rheumatoid arthritis, or temporal arteritis, examining the effects of ICT etidronate." | 5.07 | Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. ( Adachi, J; Bensen, WG; Bianchi, F; Cividino, A; Craig, GL; Cranney, A; Goldsmith, CH; Kaminska, E; Papaioannou, A; Sebaldt, RJ, 1994) |
| "Hypercalcemia was confirmed by laboratory examination." | 2.53 | Systemic lupus erythematosus-related hypercalcemia with ectopic calcinosis. ( Huang, L; Zhang, X; Zhao, L, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, L | 1 |
| Huang, L | 1 |
| Zhang, X | 1 |
| Adachi, J | 1 |
| Cranney, A | 1 |
| Goldsmith, CH | 1 |
| Bensen, WG | 1 |
| Bianchi, F | 1 |
| Cividino, A | 1 |
| Craig, GL | 1 |
| Kaminska, E | 1 |
| Sebaldt, RJ | 1 |
| Papaioannou, A | 1 |
1 review available for etidronate and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Systemic lupus erythematosus-related hypercalcemia with ectopic calcinosis.
Topics: Adult; Biomarkers; Bone Density Conservation Agents; Calcinosis; Calcitonin; Cyclophosphamide; Drug | 2016 |
1 trial available for etidronate and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.
Topics: Adrenal Cortex Hormones; Adult; Aged; Arthritis, Rheumatoid; Bone Density; Cohort Studies; Dose-Resp | 1994 |